scholarly article | Q13442814 |
P50 | author | Craig W Hendrix | Q59688777 |
Mark A Marzinke | Q88268174 | ||
Kenneth K Mugwanya | Q88429175 | ||
Timothy R Muwonge | Q88429177 | ||
Gabriel Muthuri | Q88429179 | ||
Jared M Baeten | Q89443633 | ||
Kenneth Ngure | Q89958961 | ||
Nelly Mugo | Q90832458 | ||
Elly Katabira | Q30905495 | ||
Connie Celum | Q42571941 | ||
Grace John-Stewart | Q47146705 | ||
P2093 | author name string | Andy Stergachis | |
Nulu B Semiyaga | |||
P2860 | cites work | Incident HIV infection in pregnant and lactating women and its effect on mother-to-child transmission in South Africa | Q83600075 |
Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men | Q24612082 | ||
Incident HIV during pregnancy and postpartum and risk of mother-to-child HIV transmission: a systematic review and meta-analysis | Q27010727 | ||
Antiretroviral prophylaxis for HIV prevention in heterosexual men and women | Q28270788 | ||
Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group | Q29614934 | ||
Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana | Q29620078 | ||
Pharmacokinetics of tenofovir in breast milk of lactating rhesus macaques | Q33770127 | ||
Drug therapy for breast-feeding women | Q33966064 | ||
A novel index for expressing exposure of the infant to drugs in breast milk | Q34346533 | ||
Is infant exposure to antiretroviral drugs during breastfeeding quantitatively important? A systematic review and meta-analysis of pharmacokinetic studies | Q34470986 | ||
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection | Q34503668 | ||
Concentrations of tenofovir and emtricitabine in breast milk of HIV-1-infected women in Abidjan, Cote d'Ivoire, in the ANRS 12109 TEmAA Study, Step 2 | Q34737231 | ||
Pharmacokinetics and safety of single oral doses of emtricitabine in human immunodeficiency virus-infected children | Q35005470 | ||
Drug excretion into breast milk--overview | Q35111467 | ||
Increased risk of HIV-1 transmission in pregnancy: a prospective study among African HIV-1-serodiscordant couples | Q35214337 | ||
Integrated Delivery of Antiretroviral Treatment and Pre-exposure Prophylaxis to HIV-1-Serodiscordant Couples: A Prospective Implementation Study in Kenya and Uganda | Q36110276 | ||
Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial | Q36426896 | ||
Population pharmacokinetics of emtricitabine in human immunodeficiency virus type 1-infected pregnant women and their neonates | Q37115730 | ||
Antiretroviral concentrations in breast-feeding infants of mothers receiving highly active antiretroviral therapy | Q37115759 | ||
Pharmacokinetics and safety of tenofovir in HIV-infected women during labor and their infants during the first week of life | Q37551251 | ||
Increased risk of incident HIV during pregnancy in Rakai, Uganda: a prospective study | Q38880362 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | breastfeeding | Q174876 |
anti-retroviral agent | Q50430310 | ||
P304 | page(s) | e1002132 | |
P577 | publication date | 2016-09-27 | |
P1433 | published in | PLOS MEDICINE | Q1686921 |
P1476 | title | Pre-exposure Prophylaxis Use by Breastfeeding HIV-Uninfected Women: A Prospective Short-Term Study of Antiretroviral Excretion in Breast Milk and Infant Absorption | |
P478 | volume | 13 |
Q40051192 | A Missed Opportunity for U.S. Perinatal Human Immunodeficiency Virus Elimination: Pre-exposure Prophylaxis During Pregnancy |
Q38672579 | A Review of HIV Pre-Exposure Prophylaxis: The Female Perspective |
Q64118054 | Canadian guideline on HIV preexposure prophylaxis and nonoccupational postexposure prophylaxis for pharmacists |
Q38787423 | Consensus statement: Supporting Safer Conception and Pregnancy For Men And Women Living with and Affected by HIV. |
Q40116624 | Delivering PrEP to pregnant and breastfeeding women in sub-Saharan africa: The implementation science frontier |
Q92489546 | Emerging evidence from a systematic review of safety of pre-exposure prophylaxis for pregnant and postpartum women: where are we now and where are we heading? |
Q92352371 | Evaluating the vertical HIV transmission risks among South African female sex workers; have we forgotten PMTCT in their HIV programming? |
Q64882362 | Guidelines to support HIV-affected individuals and couples to achieve pregnancy safely: Update 2018. |
Q91909107 | HIV seroconversion during pregnancy and the need for pre-exposure prophylaxis (PrEP) |
Q54260529 | Increased Risk of Female HIV-1 Acquisition Throughout Pregnancy and Postpartum: A Prospective Per-coital Act Analysis Among Women with HIV-1 Infected Partners. |
Q96308241 | Influences on willingness to use vaginal or oral HIV PrEP during pregnancy and breastfeeding in Africa: the multisite MAMMA study |
Q38657474 | Low HIV incidence in pregnant and postpartum women receiving a community-based combination HIV prevention intervention in a high HIV incidence setting in South Africa |
Q47575321 | Management of Pregnant Women and Children: Focusing on Preventing Mother-to-Infant Transmission. |
Q99555977 | Mitochondrial DNA Parameters in Blood of Infants Receiving Lopinavir/Ritonavir or Lamivudine Prophylaxis to Prevent Breastfeeding Transmission of HIV-1 |
Q38737364 | Offering pre-exposure prophylaxis for HIV prevention to pregnant and postpartum women: a clinical approach |
Q91852199 | Perceptions of HIV Preexposure Prophylaxis Among Young Pregnant Women from Rural KwaZulu-Natal, South Africa |
Q50138591 | Plasma and breast milk pharmacokinetics of emtricitabine, tenofovir and lamivudine using dried blood and breast milk spots in nursing African mother-infant pairs |
Q64119518 | PrEP Implementation for Mothers in Antenatal Care (PrIMA): study protocol of a cluster randomised trial |
Q61798882 | PrEP uptake preferences among men who have sex with men in China: results from a National Internet Survey |
Q33766562 | Pre-exposure prophylaxis for HIV prevention in women: current perspectives |
Q64067207 | Retest and treat: a review of national HIV retesting guidelines to inform elimination of mother-to-child HIV transmission (EMTCT) efforts |
Q53682339 | Risk perception and sex behaviour in pregnancy and breastfeeding in high HIV prevalence settings: Programmatic implications for PrEP delivery. |
Q38750453 | Safety of oral tenofovir disoproxil fumarate-based HIV pre-exposure prophylaxis use in lactating HIV-uninfected women |
Q58765180 | Scale up of PrEP integrated in public health HIV care clinics: a protocol for a stepped-wedge cluster-randomized rollout in Kenya |
Q47551255 | Simultaneous quantification of four antiretroviral drugs in breast milk samples from HIV-positive women by an ultra-high performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS) method |
Q36146022 | Tenofovir Pre-exposure Prophylaxis for Pregnant and Breastfeeding Women at Risk of HIV Infection: The Time is Now. |
Q56910156 | Tenofovir and tenofovir-diphosphate concentrations during pregnancy among HIV-uninfected women using oral preexposure prophylaxis |
Q42271267 | Top Questions in ID: Pre-exposure Prophylaxis for HIV. |
Search more.